Transcriptome‑based drug repositioning identifies TPCA‑1 as a potential selective inhibitor of esophagus squamous carcinoma cell viabilityZongyang Li, Jian Yang, Linjun Zou et al.|International Journal of Molecular Medicine|2022Cited by 27